Risk of overactive bladder associated with medications for dementia
Ditching cigarettes for smokeless tobacco can help cut cardiovascular risks, study finds
6 January 2022Calling Omicron ‘mild’ a mistake, warns WHO
6 January 2022Risk of overactive bladder associated with medications for dementia
A study from the University of Houston College of Pharmacy, published in the Journal of the American Geriatrics Society, has evaluated the risk of overactive bladder (OAB) as a side effect of cholinesterase inhibitor (ChEI) drugs taken for dementia and Alzheimer’s disease. The research was based on the dissertation work of the study’s first author Prajakta Masurkar.
